Your browser doesn't support javascript.
loading
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
Tanaka, Yoshiya; Matsubara, Tsukasa; Atsumi, Tatsuya; Amano, Koichi; Ishiguro, Naoki; Sugiyama, Eiji; Yamaoka, Kunihiro; Combe, Bernard G; Kivitz, Alan J; Bae, Sang-Cheol; Keystone, Edward C; Nash, Peter; Genovese, Mark; Matzkies, Franziska; Bartok, Beatrix; Pechonkina, Alena; Kondo, Akira; Ye, Lei; Gong, Qi; Tasset, Chantal; Takeuchi, Tsutomu.
Afiliação
  • Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
  • Matsubara T; Department of Orthopedics, Matsubara Mayflower Hospital, Kato, Hyogo, Japan.
  • Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Amano K; Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Hidaka, Saitama, Japan.
  • Ishiguro N; Aichi Developmental Disability Center, Kasugai, Aichi, Japan.
  • Sugiyama E; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.
  • Yamaoka K; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
  • Combe BG; Rheumatology Department, CHU Montpellier, Montpellier University, Montpellier, France.
  • Kivitz AJ; Altoona Center for Clinical Research, Duncansville, PA, USA.
  • Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Hanyang University Institute for Rheumatology Research and Hanyang University Institute of Bioscience and Biotechnology, Seoul, Korea.
  • Keystone EC; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Nash P; Griffith University of Queensland, Brisbane, Queensland, Australia.
  • Genovese M; Gilead Sciences Inc., Foster City, CA, USA.
  • Matzkies F; Gilead Sciences Inc., Foster City, CA, USA.
  • Bartok B; Gilead Sciences Inc., Foster City, CA, USA.
  • Pechonkina A; Gilead Sciences Inc., Foster City, CA, USA.
  • Kondo A; Gilead Sciences K.K., Tokyo, Japan.
  • Ye L; Gilead Sciences Inc., Foster City, CA, USA.
  • Gong Q; Gilead Sciences Inc., Foster City, CA, USA.
  • Tasset C; Galapagos NV, Mechelen, Belgium.
  • Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, and Saitama Medical University, Iruma, Saitama, Japan.
Mod Rheumatol ; 33(4): 668-679, 2023 Jul 04.
Article em En | MEDLINE | ID: mdl-35920102
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Inibidores de Janus Quinases Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: Mod Rheumatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Inibidores de Janus Quinases Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: Mod Rheumatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão